GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company with several commercial products. Its stock price reflects both current sales revenue and the results of clinical trials of new drugs, as well as a history of litigation and disputes with the FDA.
Share prices of companies in the market segment - Pharma psycho
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company focused on the development and commercialization of drugs for the treatment of central nervous system disorders, sleep disorders, and other ailments. We classify the company in the Pharmaceuticals/Psychiatry segment. The chart below illustrates the dynamics of this complex therapeutic sector.
Broad Market Index - GURU.Markets
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of sleep disorders and other diseases of the central nervous system. Its focus on this niche makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Vanda compares to it.
Change in the price of a company, segment, and market as a whole per day
VNDA - Daily change in the company's share price Vanda Pharmaceuticals
The daily price change of Vanda, a biopharmaceutical company, reflects risks associated with regulatory decisions. Change_co measures the high volatility associated with drug approvals and patent disputes. This metric is important for analyzing biotech binary events on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma psycho
Vanda Pharmaceuticals Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to VNDA, which focuses on CNS diseases, helps assess its risk compared to more diversified pharmaceutical companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Vanda is a biopharmaceutical company specializing in drugs for the treatment of diseases of the central nervous system. Neuroscience is a risky area of research. The chart below illustrates the high volatility typical of the biotech sector, reflecting the stakes associated with Vanda's developments.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vanda Pharmaceuticals
Vanda Pharmaceuticals' year-over-year performance is a story of the struggle to extend the life cycle of its key drugs and develop new ones. Its market capitalization over the past 12 months reflects patent litigation news and clinical trial results, which are crucial for the future of a company dependent on several products.
Annual dynamics of market capitalization of the market segment - Pharma psycho
Vanda Pharmaceuticals Inc. is a biopharmaceutical company with a portfolio of commercialized drugs and an R&D pipeline. The chart shows how its sales performance, clinical trial results, and patent disputes impact its performance relative to the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vanda is a biopharmaceutical company whose stock performance is driven by the success of its drug sales and progress in research. The company's business is not dependent on economic cycles. Its chart reflects biotech events rather than macroeconomic data, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vanda Pharmaceuticals
Vanda, a pharmaceutical company, depends on its product cycle for its market capitalization. Monthly fluctuations on the chart reflect sales data for its drugs and, more importantly, news of patent litigation, which creates high uncertainty.
Monthly dynamics of market capitalization of the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of sleep disorders, schizophrenia, and other central nervous system disorders. The chart below reflects the overall sentiment in the psychopharmacology sector, where breakthroughs can dramatically change the company's valuation.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vanda Pharmaceuticals is a biopharmaceutical company focused on developing drugs for the treatment of central nervous system disorders. Its shares are driven by clinical trial results, FDA decisions, and patent disputes. The company's performance is largely uncorrelated with the broader market, betting on scientific success.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vanda Pharmaceuticals
Shares of Vanda Pharmaceuticals, a biopharmaceutical company, are news-sensitive. Weekly price movements depend on sales data for its drugs, the outcome of patent litigation, and the results of clinical trials of new drugs. The chart below shows how short-term events in the pharmaceutical industry affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Pharma psycho
How typical are Vanda Pharmaceuticals' dynamics for the pharmaceutical sector? This chart compares the company's weekly stock price movements with the industry average. This helps us understand whether its reactions to sales news, patent disputes, and research are typical, or whether its niche focus on the central nervous system creates a unique trajectory.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vanda Pharmaceuticals is a biopharmaceutical company whose shares can be highly volatile. This chart compares its weekly performance to the market. It helps us understand how disconnected its stock is from the macroeconomic environment and how dependent it is entirely on research progress, litigation, and regulatory decisions.
Market capitalization of the company, segment and market as a whole
VNDA - Market capitalization of the company Vanda Pharmaceuticals
The chart below shows Vanda Pharmaceuticals' valuation, which reflects its business model, which is based on several niche drugs for sleep disorders and schizophrenia. The company's market capitalization depends on the patent protection of its drugs and the success of its new development efforts. The dynamics show how investors view its product portfolio and legal battles.
VNDA - Share of the company's market capitalization Vanda Pharmaceuticals within the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company whose market share is based on its commercial products for the treatment of sleep disorders and schizophrenia. Its market capitalization reflects both current sales and its research programs.
Market capitalization of the market segment - Pharma psycho
This chart shows the total value of niche pharmaceutical companies. Vanda Pharmaceuticals, with its focus on CNS and sleep disorders, is a prime example. The diagram illustrates the scale of the market, where even drugs for rare diseases can generate significant value.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of a biotech company focused on treating rare diseases. Vanda Pharmaceuticals' market cap reflects not only current sales but also the potential of its research programs. The line shows how science is creating its own unique and valuable niche in the global pharmaceutical industry.
Book value capitalization of the company, segment and market as a whole
VNDA - Book value capitalization of the company Vanda Pharmaceuticals
Vanda Pharmaceuticals' book value represents its intellectual capital. The chart below reflects the valuation of its patents on approved drugs for sleep disorders and psychiatric disorders. The dynamics illustrate how the company invests in research and protection of its key intangible assets.
VNDA - Share of the company's book capitalization Vanda Pharmaceuticals within the market segment - Pharma psycho
Vanda Pharmaceuticals' physical infrastructure consists of its R&D centers and laboratories for developing drugs for the treatment of central nervous system disorders. The chart shows the company's share of this specialized scientific base, which forms the foundation for the creation of innovative drugs in complex therapeutic areas.
Market segment balance sheet capitalization - Pharma psycho
Below you can see the overall book value of the pharmaceutical sector. Against this backdrop, Vanda Pharmaceuticals, as a company with commercialized products, appears more capital-intensive than an early-stage biotech. It invests not only in R&D but also in marketing and supply chains, which is reflected in its balance sheet.
Book value of all companies included in the broad market index - GURU.Markets
Vanda Pharmaceuticals is a biopharmaceutical company focused on central nervous system drugs. Its assets are not manufacturing plants, but patents for approved drugs and a pipeline of developments. The company's balance sheet is the value of its intellectual property, which treats real diseases and generates cash flow.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vanda Pharmaceuticals
Vanda's balance sheet consists of its cash and drug patents. Its market capitalization reflects the future cash flows from these drugs. The MvsBCap_Co chart shows how investors assess the longevity of these flows and the potential of the company's new developments.
Market to book capitalization ratio in a market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company developing drugs for the treatment of central nervous system diseases. The chart shows how the market values its existing products and pipeline. The premium to book value reflects the value of its intellectual property.
Market to book capitalization ratio for the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in developing drugs for the treatment of central nervous system diseases, sleep disorders, and other conditions. Its value is determined by its portfolio of approved drugs and its pipeline. This chart illustrates why pharmaceutical companies can achieve high valuations thanks to their patents.
Debts of the company, segment and market as a whole
VNDA - Company debts Vanda Pharmaceuticals
For Vanda Pharmaceuticals, debt policy is tied to funding R&D and the commercialization of its drugs. This chart shows how the company uses capital to conduct clinical trials and market its niche drugs. In pharmaceuticals, where product life cycles are long, financial management is key to bringing innovations to market.
Market segment debts - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. Unlike early-stage companies, Vanda already has commercial products but continues to invest in R&D. This chart shows how the company balances sales revenue with drug development expenses.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company focused on CNS drugs. The chart shows its capital structure. For a company whose revenue depends on the success of several key drugs and R&D, debt levels are an important indicator of financial stability. They determine its ability to survive trial failures or patent loss.
Market segment debt to market segment book capitalization - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental illnesses. Developing and commercializing drugs is an expensive process. The chart shows how the company's debt load compares to its overall market capitalization and the risks associated with the pharmaceutical industry.
Debt to book value of all companies in the market
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. The company already has commercial products. This chart shows the overall debt-to-equity ratio. It allows you to compare Vanda's debt policy, which has stable income, with that of biotech companies in the development stage.
P/E of the company, segment and market as a whole
P/E - Vanda Pharmaceuticals
This chart shows the valuation of Vanda Pharmaceuticals, a biopharmaceutical company with several drugs on the market. The price-to-earnings ratio depends on the sales volume of its key drugs and the success of expanding their indications. A decline may be due to patent expirations or unsuccessful clinical trials of new candidates.
P/E of the market segment - Pharma psycho
This chart shows the average P/E valuation for biopharmaceutical companies. For Vanda Pharmaceuticals, which already has drugs on the market, this is an important benchmark. Comparing its P/E to the industry average helps understand how investors value its current portfolio and prospects for new developments compared to other companies of its size.
P/E of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders, such as sleep disorders and schizophrenia. The company focuses on personalized medicine. This risk appetite chart helps understand how investors value specialty pharmaceutical companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders, sleep disorders, and gastroparesis. This chart reflects expectations for its current and future product lines. Estimates are based on sales volumes of existing drugs and clinical trial results for new candidates in its pipeline.
%20P%2FE%20Vanda%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Vanda-Pharmaceuticals&v=1772615956676 "Chart of the company's future (projected) P/E Vanda Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. This chart compares the company's future profitability expectations with the pharmaceutical sector average. It reflects the market's confidence in the commercial success of their existing and future drugs.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-psycho&v=1772615956690 "Future (projected) P/E graph of the market segment - Pharma psycho")
Future (projected) P/E of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and other central nervous system diseases. Its success depends on sales of existing drugs and R&D results. This graph of general market expectations influences Vanda through the overall assessment of the biotech sector and investor sentiment.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772615956693 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders, such as sleep disorders and schizophrenia. Its revenue depends on sales of approved drugs and the success of clinical trials of new candidates. This graph reflects the commercial and scientific trajectory of this complex medical field.
Profit of companies in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for sleep disorders and mental health conditions. Its success depends on sales of existing drugs and R&D. This chart shows how niche pharmaceutical companies contribute to the overall profitability of the sector by focusing on specific but important medical needs.
Overall market profit
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental illnesses. Its success is determined by clinical trial results, regulatory approvals, and patent protection. The company's business is driven by science, not economic cycles, so its performance may not align with chart trends.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. This chart shows its future revenue expectations, which depend on sales of its existing drugs, such as Hetlioz and Fanapt, as well as on the success of developing and commercializing new drugs in its pipeline.
%20profit%20of%20the%20company%20Vanda%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Vanda-Pharmaceuticals&v=1772615956771 "Graph of future (projected) profit of the company Vanda Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders. This chart shows the revenue forecast for the psychopharmaceutical sector. It reflects expected demand for new treatments for sleep disorders, schizophrenia, and other conditions, which is important for assessing Vanda's product portfolio.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-psycho&v=1772615956780 "Graph of future (predicted) profits of companies in a market segment - Pharma psycho")
Future (predicted) profit of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company focused on drugs for the treatment of sleep disorders and mental illnesses. Its sales are dependent on diagnoses and insurance coverage. Economic cycles, reflected here, affect sales indirectly through employment levels (and, therefore, insurance coverage) and overall healthcare costs.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772615956796 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company that develops and markets drugs for the treatment of sleep disorders and other central nervous system diseases. This chart shows how investors view its current sales and the potential of new drugs in development, taking into account patent risks and competition in the pharmaceutical industry.
P/S market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of central nervous system disorders, such as sleep disorders and schizophrenia. This chart shows the average valuation in the sector, helping to understand how the market values Vanda's existing pipeline and R&D efforts.
P/S of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of central nervous system disorders, such as sleep disorders and schizophrenia. This market valuation chart helps understand the premium investors are willing to pay for the potentially high but risky revenue potential of this niche biotech.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company with products already on the market. Its future revenue depends on both sales of existing drugs and the success of new developments in its pipeline. This chart reflects investor expectations regarding sales growth and the potential of its research programs.
%20P%2FS%20Vanda%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Vanda-Pharmaceuticals&v=1772615956874 "The graph of the company's future (projected) P/S Vanda Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders. This chart compares market expectations for its future revenue with other psychopharmaceutical companies. The valuation reflects investor opinions on its commercial products and clinical pipeline.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-psycho&v=1772615956886 "Future (projected) P/S market segment graph - Pharma psycho")
Future (projected) P/S of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company focused on developing drugs for the central nervous system. Its success depends on the results of clinical trials. However, the overall optimism evident in this chart creates a favorable environment for research funding and increases the market's willingness to pay for innovative drugs in complex therapeutic areas.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772615956908 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of sleep disorders and other central nervous system diseases. The company's revenue is generated from sales of its approved drugs. This chart shows the commercial success of these products and demand for them from patients and physicians.
Sales of companies in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of diseases of the central nervous system. Its portfolio includes several approved drugs, the revenue from which generates its primary cash flow. This chart illustrates the dynamics of the pharmaceutical market, where Vanda's success depends on sales of existing products and the development of new ones.
Overall market sales
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental illnesses. Its success depends on sales of existing drugs and the results of clinical trials. The connection to the economy, reflected in the graph, is indirect—through the overall health of the healthcare system and its ability to pay for treatment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders, schizophrenia, and other central nervous system disorders. Revenue forecasts are dependent on sales of existing drugs and the success of new developments. This chart reflects analyst expectations for sales growth for the company's key products.
%20sales%20of%20the%20company%20Vanda%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Vanda-Pharmaceuticals&v=1772615956977 "Schedule of future (projected) sales of the company Vanda Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders. This chart shows general forecasts for psychopharmaceuticals. It allows one to assess how sales of existing drugs and progress in developing new ones impact the company's prospects within its therapeutic niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-psycho&v=1772615957048 "Schedule of future (projected) sales of companies in the market segment - Pharma psycho")
Future (projected) sales of the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental health conditions. This chart, reflecting the state of the healthcare system, is important to Vanda. Economic stability ensures the solvency of patients and insurers, which allows the company to generate revenue from its commercialized products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772615957074 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of central nervous system disorders. Its success depends on patent protection and effective marketing. This chart shows how the company converts sales of its niche drugs into net profit after deducting R&D costs.
Market segment marginality - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental illnesses. The company's profitability depends on sales of its existing drugs and the success of their R&D pipeline. This chart shows how effectively the company manages its commercial pipeline and invests in future growth compared to other pharmaceutical companies.
Market marginality as a whole
Vanda Pharmaceuticals is a biopharmaceutical company with several commercial products. Unlike the general picture of profitability, their history is one of trying to maximize sales of existing drugs and bring new ones to market. Their profitability depends on patent protection, insurance company decisions, and the success of their R&D, rather than on general economic cycles.
Employees in the company, segment and market as a whole
Number of employees in the company Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental health conditions. This graph shows the team, including both research and commercial teams. The size of the team reflects the balance between developing new drugs and marketing existing ones.
Share of the company's employees Vanda Pharmaceuticals within the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs for the treatment of central nervous system disorders. This chart shows the proportion of specialists in the psychopharmacology niche the company attracts. This demonstrates its focus on complex diseases and its team working to develop innovative treatments.
Number of employees in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and other central nervous system diseases. This chart illustrates employment in the pharmaceutical industry. A stable staff of researchers and commercial specialists is essential for the development and commercialization of niche drugs.
Number of employees in the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the development of drugs to treat central nervous system disorders, such as schizophrenia and sleep disorders. This chart reflects overall employment, and in this picture, research-intensive companies like Vanda play a special role, creating high-paying jobs for scientists, doctors, and researchers.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals is a biopharmaceutical company developing and marketing drugs for the treatment of central nervous system diseases. This chart illustrates a model where value is created through drug patents. The high capitalization per employee reflects the fact that a small team of scientists and marketers can manage a product with multimillion-dollar sales, protected by intellectual property.
%20of%20the%20company%20Vanda%20Pharmaceuticals%20(VNDA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Vanda-Pharmaceuticals-VNDA&v=1772615957187 "Chart of market capitalization per employee (in thousands of dollars) of the company Vanda Pharmaceuticals (VNDA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. Its value is determined by its pipeline of approved drugs and promising pipelines. The chart shows how the market values the productivity of its R&D and commercial teams per employee, reflecting its belief in its scientific and market success.
%20by%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-psycho&v=1772615957193 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma psycho")
Market capitalization per employee (in thousands of dollars) for the overall market
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders. Its value is based on its existing products and R&D. This chart shows how the market values its team's ability to develop and commercialize niche drugs, where intellectual property is the primary asset.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772615957222 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company with commercialized drugs (for example, for sleep disorders). This chart shows how efficient their business model is. It measures how much net profit each employee generates, including the sales team, which promotes these niche drugs, and the R&D team, which is researching new ones.
%20Chart%20Vanda%20Pharmaceuticals%20(VNDA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Vanda-Pharmaceuticals-VNDA&v=1772615957235 "Company Profit Per Employee (in thousands of dollars) Chart Vanda Pharmaceuticals (VNDA)")
Profit per employee (in thousands of dollars) in the market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company with commercially available drugs (Hetlioz, Fanapt). Their business includes both sales of existing drugs and R&D for new ones. This chart shows the benchmark for employee profitability in the pharmaceutical industry. It is important for assessing how effectively the Vanda team manages its portfolio and generates profit.
%20in%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-psycho&v=1772615957258 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma psycho")
Profit per employee (in thousands of dollars) for the market as a whole
Vanda Pharmaceuticals is a biopharmaceutical company with commercial products (for example, for treating sleep disorders). Unlike purely R&D biotech companies, Vanda already generates revenue. This chart shows the balance between R&D spending (discovering new drugs) and commercial efficiency (selling existing ones). This is a mature model, where profit per employee should be stable.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772615957285 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and mental illnesses. This graph shows the life cycle of its products. Revenue per employee depends on patent protection and sales of key drugs, as well as the successful launch of new drugs in its portfolio.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Vanda-Pharmaceuticals-VNDA&v=1772615957336 "Sales chart per company employee Vanda Pharmaceuticals (VNDA)")
Sales per employee in the market segment - Pharma psycho
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company with drugs for sleep disorders and schizophrenia. This chart shows how much revenue each employee (including sales and R&D) generates from drug sales. This is an indicator of the commercial viability of their products and R&D productivity compared to other pharmaceutical companies.
Sales per employee for the market as a whole
Vanda Pharmaceuticals is a biotech company with commercial products (Hetlioz, Fanapt) targeting sleep disorders and mental health conditions. This chart shows how successfully their commercial team is selling these niche drugs. Unlike R&D companies, this chart shows the actual output of their commercial team.
Short shares by company, segment and market as a whole
Shares shorted by company Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals is a biopharmaceutical company with several approved drugs for sleep disorders and mental health conditions. This chart shows bearish bets. The shorts may be related to the expiration of patent protection on their key drugs, paving the way for cheaper generics and threatening a collapse in revenue.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Vanda-Pharmaceuticals-VNDA&v=1772615957571 "Short Shares Chart for the Company Vanda Pharmaceuticals (VNDA)")
Shares shorted by market segment - Pharma psycho
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company specializing in drugs for the treatment of sleep disorders and central nervous system disorders (such as schizophrenia). This chart shows bets against the specialty pharmaceutical sector. The rising bets against the industry may reflect investor concerns about patent expirations on Vanda's key drugs, which would lead to a sharp decline in revenue.
Shares shorted by the overall market
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company focused on CNS drugs. The company has approved products, but it also relies on R&D. This general fear chart is important. During periods of panic, investors may ignore VNDA's stable sales and focus on R&D risks, dumping the stock along with other biotechs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals is a biopharmaceutical company with several approved but niche drugs (for sleep and schizophrenia). This chart measures how investors view their portfolio. It shows when the stock is "overbought" on news of legal victories or "oversold" on weak sales.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Vanda-Pharmaceuticals-VNDA&v=1772615957710 "RSI 14 indicator chart for the company's stock Vanda Pharmaceuticals (VNDA)")
RSI 14 Market Segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders, such as sleep disorders and schizophrenia. This chart measures the overall momentum in the CNS pharmaceutical sector. It helps separate patent-related VNDA volatility from the overall industry trend.
RSI 14 for the overall market
Vanda Pharmaceuticals, a biotech company whose fate depends on this schedule, requires a constant influx of capital to fund expensive clinical trials. During periods of market euphoria, investors generously fund risky developments. During periods of panic, the "cash spigot" is turned off, and companies like VNDA are forced to struggle to survive.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VNDA (Vanda Pharmaceuticals)
Vanda Pharmaceuticals is a biopharmaceutical company focused on drugs for sleep disorders (Hetlioz) and schizophrenia (Fanapt). This chart shows the average analyst forecast. Their targets are based on sales growth of existing drugs, success in R&D, and patent protection.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VNDA-Vanda-Pharmaceuticals&v=1772615957731 "A chart showing analyst consensus forecasts for the expected stock price. VNDA (Vanda Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price VNDA (Vanda Pharmaceuticals)
Vanda Pharmaceuticals (VNDA) is a biopharmaceutical company specializing in drugs for sleep disorders (Hetlioz) and schizophrenia (Fanapt). This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting whether analysts believe their pipeline can offset future patent collapses.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VNDA-Vanda-Pharmaceuticals&v=1772615957746 "A chart showing the difference between the consensus forecast and the actual stock price. VNDA (Vanda Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company whose primary revenue comes from drugs for rare sleep disorders (Hetlioz) and schizophrenia (Fanapt). This chart shows analysts' overall expectations for the pharmaceutical (psychology) sector. It reflects whether experts believe in the growth of niche CNS markets.
Analysts' consensus forecast for the overall market share price
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for sleep disorders and mental health conditions. This chart shows overall market sentiment. For Vanda, which operates in the defensive healthcare sector, overall optimism is important, but their business depends more on the success of clinical trials and patent protection for their niche drugs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biotech company whose fate is tied to two commercial products (Hetlioz, Fanapt) and a risky R&D pipeline in psychiatry and gastroenterology. This chart is a summary indicator of their battle. It reflects their ability to protect their key drugs from generics and their progress in clinical trials.
AKIMA Market Segment Index - Pharma psycho
Vanda Pharmaceuticals is a biopharmaceutical company specializing in drugs for the treatment of central nervous system disorders, such as schizophrenia and sleep disorders. This chart shows the average index for the pharmaceutical sector. It allows you to assess how Vanda, with its narrow focus, compares to the average pharmaceutical company based on a combination of factors.
The AKIM Index for the overall market
Vanda Pharmaceuticals is a biopharmaceutical company specializing in the treatment of sleep and circadian rhythm disorders (Hetlioz, Fanapt). This chart, which reflects the market average, provides a macro backdrop. It helps assess how this mature biotech company, which protects its patents, compares to the broader economic trends affecting the sector.
